PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC
Therapeutic Area: Preventive Cardiology Best Practices Background: Patients with dyslipidemia, obesity, diabetes, hypertension, and renal impairment are at high risk for cardiovascular diseases. Contemporary preventative strategies are complex. In Canada, care gaps exist in preventative medicine. We...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | American Journal of Preventive Cardiology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667722000940 |
| _version_ | 1797946174493163520 |
|---|---|
| author | Daniel Esau Beth Abramson |
| author_facet | Daniel Esau Beth Abramson |
| author_sort | Daniel Esau |
| collection | DOAJ |
| description | Therapeutic Area: Preventive Cardiology Best Practices Background: Patients with dyslipidemia, obesity, diabetes, hypertension, and renal impairment are at high risk for cardiovascular diseases. Contemporary preventative strategies are complex. In Canada, care gaps exist in preventative medicine. We discuss the development of an academic intra-disciplinary cardiometabolic clinic. Its aim is to improve preventative care for patients and educate trainees and health care providers. Methods: A multidisciplinary advisory team was convened in Jan 2021. Infrastructure was created, including a clinic referral form, a patient satisfaction survey, a clinic database, and a web presence for patient education. Metrics include patient satisfaction, biometrics, laboratory values, test results, and medications. Results: In the first 6 months, 95 patients have been referred to the cardiometabolic clinic, most through primary care. 12.6% had a statin indicated condition, and 14.7%, 24.2%, and 30.5% were at high, medium, and low cardiovascular risk based on the Framingham Risk Score. On the first visit, 62% had a statin added or their statin dose increased, and 78% have had their medications adjusted in some way. The use of high sensitivity troponin I (hsTnI) as a biomarker was high, with 64% of patients having hsTnI measured. 90% of patients were either “satisfied” or “very satisfied” with their appointment, and patients reported improvement in their understanding of their cardiovascular risk. Conclusion: Development of a novel cardiometabolic clinic in a Canadian environment is possible. Initial results are promising and shows improvement in evidence based medical therapy. Most patients had medications adjusted and high satisfaction with their visit. Ongoing evaluation will examine long term medication adherence. Development of a “learner's toolkit” for residents and fellows is underway. |
| first_indexed | 2024-04-10T21:06:42Z |
| format | Article |
| id | doaj.art-9919ab0092a54ff292ddfb11cc700bd9 |
| institution | Directory Open Access Journal |
| issn | 2666-6677 |
| language | English |
| last_indexed | 2024-04-10T21:06:42Z |
| publishDate | 2023-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Preventive Cardiology |
| spelling | doaj.art-9919ab0092a54ff292ddfb11cc700bd92023-01-22T04:42:20ZengElsevierAmerican Journal of Preventive Cardiology2666-66772023-03-0113100410PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINICDaniel Esau0Beth Abramson1St. Michael's Hospital in Toronto, Ontario, CanadaSt. Michael's Hospital in Toronto, Ontario, CanadaTherapeutic Area: Preventive Cardiology Best Practices Background: Patients with dyslipidemia, obesity, diabetes, hypertension, and renal impairment are at high risk for cardiovascular diseases. Contemporary preventative strategies are complex. In Canada, care gaps exist in preventative medicine. We discuss the development of an academic intra-disciplinary cardiometabolic clinic. Its aim is to improve preventative care for patients and educate trainees and health care providers. Methods: A multidisciplinary advisory team was convened in Jan 2021. Infrastructure was created, including a clinic referral form, a patient satisfaction survey, a clinic database, and a web presence for patient education. Metrics include patient satisfaction, biometrics, laboratory values, test results, and medications. Results: In the first 6 months, 95 patients have been referred to the cardiometabolic clinic, most through primary care. 12.6% had a statin indicated condition, and 14.7%, 24.2%, and 30.5% were at high, medium, and low cardiovascular risk based on the Framingham Risk Score. On the first visit, 62% had a statin added or their statin dose increased, and 78% have had their medications adjusted in some way. The use of high sensitivity troponin I (hsTnI) as a biomarker was high, with 64% of patients having hsTnI measured. 90% of patients were either “satisfied” or “very satisfied” with their appointment, and patients reported improvement in their understanding of their cardiovascular risk. Conclusion: Development of a novel cardiometabolic clinic in a Canadian environment is possible. Initial results are promising and shows improvement in evidence based medical therapy. Most patients had medications adjusted and high satisfaction with their visit. Ongoing evaluation will examine long term medication adherence. Development of a “learner's toolkit” for residents and fellows is underway.http://www.sciencedirect.com/science/article/pii/S2666667722000940 |
| spellingShingle | Daniel Esau Beth Abramson PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC American Journal of Preventive Cardiology |
| title | PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC |
| title_full | PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC |
| title_fullStr | PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC |
| title_full_unstemmed | PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC |
| title_short | PRIORITIZING PREVENTION AND CLOSING CARE GAPS: DEVELOPMENT OF A CANADIAN CARDIOMETABOLIC PREVENTION CLINIC |
| title_sort | prioritizing prevention and closing care gaps development of a canadian cardiometabolic prevention clinic |
| url | http://www.sciencedirect.com/science/article/pii/S2666667722000940 |
| work_keys_str_mv | AT danielesau prioritizingpreventionandclosingcaregapsdevelopmentofacanadiancardiometabolicpreventionclinic AT bethabramson prioritizingpreventionandclosingcaregapsdevelopmentofacanadiancardiometabolicpreventionclinic |